Technical Analysis for NVCN - Neovasc Inc

Grade Last Price % Change Price Change
grade B 4.39 1.39% 0.060
NVCN closed up 1.39 percent on Friday, June 5, 2020, on 84 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical NVCN trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Bearish Engulfing Bearish 1.39%
Upper Bollinger Band Walk Strength 1.39%
Wide Bands Range Expansion 1.39%
Overbought Stochastic Strength 1.39%
Upper Bollinger Band Touch Strength 1.39%
Spinning Top Other 0.23%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
Medical Specialties Stainless Steel Tissue Products Heart Diseases

Is NVCN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 11.2
52 Week Low 0.61
Average Volume 16,988
200-Day Moving Average 3.951
50-Day Moving Average 3.333
20-Day Moving Average 3.869
10-Day Moving Average 4.127
Average True Range 0.257
ADX 32.87
+DI 31.675
-DI 11.623
Chandelier Exit (Long, 3 ATRs ) 3.680
Chandelier Exit (Short, 3 ATRs ) 4.030
Upper Bollinger Band 4.488
Lower Bollinger Band 3.250
Percent B (%b) 0.92
BandWidth 31.982
MACD Line 0.258
MACD Signal Line 0.218
MACD Histogram 0.04
Fundamentals Value
Market Cap 346.42 Million
Num Shares 78.9 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -62.71
Price-to-Sales 15.76
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.675
Resistance 3 (R3) 4.650 4.530 4.628
Resistance 2 (R2) 4.530 4.457 4.543 4.612
Resistance 1 (R1) 4.460 4.413 4.495 4.485 4.596
Pivot Point 4.340 4.340 4.358 4.353 4.340
Support 1 (S1) 4.270 4.267 4.305 4.295 4.184
Support 2 (S2) 4.150 4.223 4.163 4.168
Support 3 (S3) 4.080 4.150 4.153
Support 4 (S4) 4.105